Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07671794
Enrolling by invitation Not applicable

Maxillary Positioning in Orthognathic Surgery

NCT07671794 · tracked via the Priya Life Science Egypt tracker
Sponsor
Future University in Egypt
Phase
Not applicable
Started
2026-06-15
Last updated
2026-06-26

Condition(s) studied

Orthognathic Surgical ProceduresPatient Specific Implant

Investigational drug(s) / intervention(s)

Maxillary Orthognathic Surgery

Maxillary Orthognathic Surgery: Maxillary Positioning using PSI or Occlusal Waver

Study summary

Patient that need corrective Jaw Surgery went into Maxillary Positioning in one of two groups either Maxilla Fixed using occlusal waver or PSI

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inculsion Criteria * Adult patients with dentofacial deformities, including skeletal Class II deformity, skeletal Class III deformity, vertical maxillary excess, and facial asymmetry. * Patients seeking definitive surgical correction and declining orthodontic camouflage treatment. * Cases required maxillary impaction, advancement, or rotational movements. Exclusion Criteria: Medically compromised patients. * Uncooperative or noncompliant patients. * Patients with poor oral hygiene or active periodontal disease.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Dental School Cairo Egypt

More Future University in Egypt trials in Egypt

The Impact of Using Different Final Irrigation Modes on Postoperative Pain Following Root Canal Treatment of Non-vital Mandibular First Molar With Periapical Lesion. Active, not recruiting
Evaluation of Zygomatic Implant Placement Accuracy Using Fully Metallic vs Resin-based Static Surgical Guides in Severely Atrophic Maxilla Recruiting
Evaluation of Postoperative Pain and Bacterial Load After Hyalone or Calcium Hydroxide Medication in Mandibular First Molars Active, not recruiting
Effect of Systemic Vitamin D on Dental Implant Osseointegration Recruiting
Evaluation of the Clinical Performance of a Bulk Fill Resin Composite in Cuspal Coverage Restorations of Vital Posterior Teeth (RCT) Active, not recruiting

Other trials for the same condition

Facial Conformation Meshes for Orthognathic Surgery Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07671794 on ClinicalTrials.gov ↗ ← All trials in Egypt